Topical preparations containing BGP-15
| dc.contributor.advisor | Ujhely, Zoltan | |
| dc.contributor.advisordept | Pharmaceutical Technology | hu_HU |
| dc.contributor.author | Irani, Tabasom | |
| dc.contributor.department | DE--Gyógyszerésztudományi Kar | hu_HU |
| dc.contributor.opponent | Harda, Kristof | |
| dc.contributor.opponent | Ildiko, Bacskay | |
| dc.contributor.opponentdept | Debreceni Egyetem::Gyógyszerésztudományi Kar::Biofarmácia Tanszék | hu_HU |
| dc.contributor.opponentdept | Debreceni Egyetem::Gyógyszerésztudományi Kar::Gyógyszertechnológiai Tanszék | hu_HU |
| dc.date.accessioned | 2020-05-06T11:55:35Z | |
| dc.date.available | 2020-05-06T11:55:35Z | |
| dc.date.created | 2020-05-06 | |
| dc.description.abstract | BGP-15 is a novel molecule with versatile activities.BGP-15 is currently in human clinical trials for the insulin resistance indications and treatment of diabetic patients primarily, but it has proved to be a useful tool in several other diseases as well, for being a chemo-protective agent and its ability to improve the muscle strength and to reduce Reactive Oxygen Spices(ROS) production. In this review we demonstrated its anti-inflammatory effects in the form of ointments. | hu_HU |
| dc.description.course | gyógyszerész | hu_HU |
| dc.description.courselang | angol | hu_HU |
| dc.description.degree | egységes, osztatlan | hu_HU |
| dc.format.extent | 30 | hu_HU |
| dc.identifier.uri | http://hdl.handle.net/2437/285879 | |
| dc.language.iso | en | hu_HU |
| dc.subject | BGP-15 Topical Administration | hu_HU |
| dc.subject.dspace | DEENK Témalista::Orvostudomány::Gyógyszerésztudomány | hu_HU |
| dc.title | Topical preparations containing BGP-15 | hu_HU |